Rao et al. examined EZH2 expression patterns in 179 ovarian carcinomas and detected positive EZH2 staining in 49.7% of cases, while no immunoreactivity was seen in normal ovarian tissue [20]. The gene discussed is EZH2; the disease is ovarian carcinoma.